Core Viewpoint - The UAE's Emirates Drug Administration (EDE) signed two memorandums of understanding during the World Health Expo in Dubai, aimed at advancing health economics, regulatory innovation, and green laboratory construction [1] Group 1: Collaborations and Initiatives - EDE partnered with the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) to promote the development of health economics [1] - EDE also collaborated with Roche Diagnostics Middle East to enhance regulatory innovation and green laboratory initiatives [1] Group 2: Technological Advancements - EDE showcased the "Organ-on-a-Chip" project, which utilizes micro-engineered chips to simulate human organ functions for precise drug efficacy and toxicity testing [1] - This technology aims to reduce reliance on animal testing and accelerate the research and development process [1] Group 3: Strategic Goals - The initiatives are designed to improve evidence-based decision-making capabilities and enhance national drug safety levels [1] - These efforts reinforce the UAE's position as a regional hub for medical regulation and innovation [1]